Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
KLK4
REST API REST API
Homo sapiens
KLK4 is differentially expressed in 122 experiments: 53 organism parts: prostate, accumbens, ... (51 more);, 64 disease states: normal, prostate carcinoma, ... (62 more);, 45 cell types 110 cell lines 13 compound treatments and 47 other conditions.
Synonyms PRSS17, KLK-L1, EMSP, EMSP1, PSTS
Orthologs F1MLB5_BOVIN (Bos taurus)   Klk4 (Mus musculus)   Klk4 (Rattus norvegicus)   KLK4 (Canis familiaris)   (Compare orthologs)
Gene Ontology Term peptidase activity, metal ion binding, extracellular region, serine-type peptidase activity, proteolysis, catalytic activity, serine-type endopeptidase activity
InterPro Term Peptidase_S1A, Peptidase_S1_S6
UniProt Accession Q96JD9, Q9Y5K2, Q96RU5, Q96PT1
Gene-Disease Assocation AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA1; AI2A1
Search EB-eye ENSG00000167749
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-8167, E-MTAB-37, E-AFMX-5, E-GEOD-803, E-GEOD-6573, ... (12 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-14464, E-GEOD-19639, E-GEOD-24147, E-GEOD-19480, ... (14 experiments)

Factor Value U/D Experiments
MCF-7
3
E-GEOD-5823, E-GEOD-20081, E-GEOD-19639
LNCaP
2
E-GEOD-14990, E-GEOD-14464
COLO320DM
1
E-MTAB-37
CROAP2
1
E-MTAB-37
HCC1395
1
E-MTAB-37
NALM1
1
E-MTAB-37
104 more value(s).


Cell type

studied in E-GEOD-18811, E-GEOD-22373, E-GEOD-20033, E-GEOD-5099, E-TABM-130, ... (20 experiments)

Factor Value U/D Experiments
memory B cell
2
E-MEXP-2360, E-TABM-702
dendritic cell
1
E-MEXP-2019
SCC
1
E-GEOD-19188
M1 macrophage
1
1
E-GEOD-5099
stromal cell
1
E-GEOD-3998
plasmablast
1
E-MEXP-2360
39 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-6872, E-GEOD-15960, E-MEXP-2069, E-GEOD-16363, ... (27 experiments)

Factor Value U/D Experiments
prostate carcinoma
3
E-GEOD-7307, E-MEXP-2034, E-MTAB-37
papillary lung adenocarcinoma
1
E-MTAB-37
spastic paraplegia
1
E-GEOD-3307
poliovirus-infected
1
E-MEXP-1072
ovarian serous adenocarcinoma
1
E-MTAB-37
bronchogenic carcinoma
1
E-MTAB-37
58 more value(s).


Compound treatment

studied in E-GEOD-3284, E-GEOD-6400, E-GEOD-5099, E-MEXP-2590, E-GEOD-7307, ... (6 experiments)

Factor Value U/D Experiments
none
1
E-GEOD-7307
Cxcl12
1
1
E-GEOD-7307
actinomycin D
1
1
E-GEOD-6400
estradiol
1
E-GEOD-20081
TTA
1
1
E-MEXP-2590
unknown
1
E-GEOD-7307
7 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
DMSO
1
1
E-GEOD-19519
thapsigargin
1
1
E-GEOD-19519
tunicamycin
1
1
E-GEOD-19519


Biosource provider
studied in E-MTAB-37, E-GEOD-20559

BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Cancer site
studied in E-GEOD-4271

Cell treatment
studied in E-MEXP-1192

Clinical history
studied in E-GEOD-19420, E-GEOD-19743, E-GEOD-7967, E-GEOD-21374, E-GEOD-21589, ... (6 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-21374, E-GEOD-21589, E-GEOD-16363, ... (6 experiments)

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-19743, E-GEOD-4667

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-19743, E-GEOD-3325, E-GEOD-21138

Environmental stress
studied in E-GEOD-1643

Estrogen receptor status
studied in E-GEOD-6532

family id
studied in E-GEOD-19519

Family relationship
studied in E-MEXP-1425

Genetic modification
studied in E-GEOD-8023, E-MEXP-1482, E-GEOD-20847, E-MTAB-108

Genotype
studied in E-TABM-1029, E-GEOD-22056, E-GEOD-17476, E-MEXP-421, E-GEOD-17347 ... (5 experiments)

Gestation age
studied in E-GEOD-14334

Histology
studied in E-GEOD-21653, E-TABM-276

Individual
studied in E-MTAB-197, E-TABM-325, E-TABM-740, E-MEXP-2069, E-GEOD-19330, ... (19 experiments)

Infection
studied in E-GEOD-12108, E-GEOD-12254, E-MEXP-561

Injury
studied in E-GEOD-19743

Ki67 ihc
studied in E-GEOD-21653

Material type
studied in E-GEOD-9171

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

organ
studied in E-GEOD-24283

Organism
studied in E-TABM-84

Organism status
studied in E-GEOD-19188

Original diagnosis
studied in E-GEOD-21521

Phase
studied in E-GEOD-4888

Population
studied in E-GEOD-4922, E-GEOD-4342

Progesterone receptor status
studied in E-GEOD-6532

Protocol type
studied in E-GEOD-22097, E-GEOD-19246

RNAi
studied in E-MEXP-1857

Sample preparation
studied in E-GEOD-16728, E-GEOD-12710

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743, E-GEOD-21374, E-GEOD-17400

Sex
studied in E-GEOD-1643, E-GEOD-7307

Stimulation
studied in E-GEOD-20114, E-GEOD-11428

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-3494, E-GEOD-4922, E-GEOD-19188

Test result
studied in E-TABM-276

Transfection
studied in E-GEOD-14680

Treatment
studied in E-GEOD-33562, E-GEOD-16837, E-GEOD-19246

Tumor grading
studied in E-GEOD-4271

Processing time: 0.329 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM